Immunovant, Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

26.18

+0.16 (0.61%)

At close: Jan 22, 2026, 4:00 PM EST

26.18

0.00 (0.00%)

After-hours: Jan 22, 2026, 4:33 PM EST

Immunovant Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Jan '26 Jan 22, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2018 - 2020
Market Capitalization	5,306	2,903	4,694	2,005	641	1,571	Upgrade
Market Cap Growth	45.70%	-38.16%	134.16%	212.60%	-59.19%	84.72%	Upgrade
Enterprise Value	4,784	2,528	4,004	1,574	117	1,153	Upgrade
Last Close Price	26.18	17.09	32.31	15.51	5.51	16.04	Upgrade
PB Ratio	8.79	4.10	7.60	5.53	1.37	4.01	Upgrade
P/TBV Ratio	10.21	4.10	7.60	5.53	1.37	4.01	Upgrade
Debt / Equity Ratio	-	0	0	0.00	0.01	0.01	Upgrade
Quick Ratio	8.28	10.42	13.18	8.72	11.38	21.38	Upgrade
Current Ratio	9.07	11.16	13.70	9.34	11.52	21.79	Upgrade
Return on Equity (ROE)	-95.93%	-62.46%	-52.91%	-50.69%	-36.39%	-44.25%	Upgrade
Return on Assets (ROA)	-55.42%	-37.97%	-31.50%	-28.26%	-21.02%	-25.90%	Upgrade
Return on Invested Capital (ROIC)	-62.85%	-41.32%	-34.41%	-31.14%	-22.49%	-27.46%	Upgrade
Return on Capital Employed (ROCE)	-93.70%	-61.90%	-43.70%	-57.40%	-33.10%	-27.50%	Upgrade
Earnings Yield	-8.76%	-14.26%	-5.52%	-10.52%	-24.44%	-6.84%	Upgrade
FCF Yield	-8.13%	-12.97%	-4.57%	-9.40%	-16.59%	-5.32%	Upgrade
Buyback Yield / Dilution	-12.85%	-9.76%	-12.21%	-12.21%	-24.98%	-103.14%	Upgrade

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q